Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 17
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (636)
- Volume 17, 2024 (15)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 17, 2024
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024
ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
Deng X, Guo X, Chen X, Zeng X, Guo J, Bai X, Zhang P, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:163-169
Published Date: 20 April 2024
Identification of a Novel Mitochondrial tRNA Mutation in Chinese Family with Type 2 Diabetes Mellitus
Li X, Shang J, Li S, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:149-161
Published Date: 17 April 2024
Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD
Xu H, Zhang H, Sun S, Zhang J, Huo J, Zhou C
Pharmacogenomics and Personalized Medicine 2024, 17:133-148
Published Date: 16 April 2024
Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype
Zhang D, Bai J
Pharmacogenomics and Personalized Medicine 2024, 17:125-131
Published Date: 16 April 2024
Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development
Zhao Z, Xing N, Guo H, Li J, Sun G
Pharmacogenomics and Personalized Medicine 2024, 17:105-123
Published Date: 11 April 2024
Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
Guo S, Bai W, Cui F, Chen X, Fang X, Shen H, Gu X
Pharmacogenomics and Personalized Medicine 2024, 17:91-103
Published Date: 3 April 2024
The Association Between Mitochondrial tRNAGlu Variants and Hearing Loss: A Case-Control Study
Yu X, Li S, Guo Q, Leng J, Ding Y
Pharmacogenomics and Personalized Medicine 2024, 17:77-89
Published Date: 28 March 2024
Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways
Lin H, Ni L, Phuong C, Hong JC
Pharmacogenomics and Personalized Medicine 2024, 17:65-76
Published Date: 13 February 2024
Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes
Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL
Pharmacogenomics and Personalized Medicine 2024, 17:53-64
Published Date: 3 February 2024
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
Montrasio C, Cheli S, Clementi E
Pharmacogenomics and Personalized Medicine 2024, 17:51-52
Published Date: 30 January 2024
The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period
Lilic J, Marjanovic VG, Budic I, Stefanovic N, Stokanovic D, Marjanovic GT, Jevtovic-Stoimenov T, Golubovic M, Zecevic M, Velickovic-Radovanovic R
Pharmacogenomics and Personalized Medicine 2024, 17:41-49
Published Date: 30 January 2024
FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults
Zhang M, Chen F, Feng S, Liu X, Wang Z, Shen N, Meng L, Zhu D, Zhu Z
Pharmacogenomics and Personalized Medicine 2024, 17:27-40
Published Date: 19 January 2024
Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene
Wang C, Deng X, Li L, Li M
Pharmacogenomics and Personalized Medicine 2024, 17:13-26
Published Date: 9 January 2024
circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer
Zhou H, Cui X, Zhu L, Xu Z, Wang Z, Shao J
Pharmacogenomics and Personalized Medicine 2024, 17:1-11
Published Date: 5 January 2024